Composition of PIF's Board in 2022
Our association elected in the Autumn General Meeting on 29 November 2021 its Board for 2022. The Board will elect the Chairperson and the 1st and 2nd Vice Chairpersons from among the Board Members at its first meeting at the beginning of February.
New Board members are Simone Böhrer (BMS), Tomer Feffer (Bayer) and Tanja Veikkola (GSK). Mikko Fernström (Biogen) and Anna Manner-Raappana (Roche) were re-elected to the Board.
Matthew Iles (AbbVie), Johanna Bexar-Hannula (Merck), Nina Ekholm-Wenberg (Janssen), Niilo Färkkilä (Amgen), Petri Lehto (MSD), Deb Mangone (Pfizer) and Jenni Vuola (Sanofi) will continue in the Board.